Session

Overview: Course aims: - Provide a general introduction to tumour immunology - Provide an outline of the interplay between radiotherapy and immune system - Understand emerging mechanisms of response and resistance to RT and immune checkpoint inhibitors - Outline novel therapeutic approaches to overcoming therapeutic resistance – moving beyond immune checkpoint inhibitors - To discuss progress and uncertainties of the immunoregulatory effects of Radiotherapy planning including volume, dose and fractionation Learning objectives: - An introduction to tumour immunolog - An introduction to the complexities of the immunomodulatory properties of radiotherapy - To gain an understanding of the current Clinical landscape of progress and challenges with radiotherapy and Immuno-Oncology agents combinations - To understand therapeutic opportunities in combining RT and Immune oncology agents to inform future clinical design Who should attend: Radiation oncologists (faculty and trainees), scientists, medical physicists, medical oncologists.